ReviewCellular and molecular life sciences : CMLS2026
The gut as a central hub for multi-organ crosstalk in aging.
Review in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The progression from aberrant DNA epigenetic modifications at the molecular level to the functional decline of cells, and subsequently to the deterioration of tissues and organs, represents a central process that shapes organismal health and aging. Aging of individual organs and the diseases associated with this process, including the decline of intestinal, skeletal muscle, cerebral, cardiac, hepatic, pulmonary and renal function, constitute key manifestations of systemic ageing and major contributors to reduced lifespan. The maintenance of organ and whole-body energy metabolism depends fundamentally on the digestion and absorption of nutrients following their entry into the intestinal tract. In recent years, the gut microbiota has emerged as a critical regulator of physiological and pathological communication among the intestine, muscle, brain, heart, liver, lungs and kidneys. It is now recognized as an important determinant of both health maintenance and disease progression. This Review presents the first comprehensive synthesis of the interactions between the gut microbiota and multi-organ ageing. It systematically examines how intestinal ageing and microbiota dysbiosis, acting through inflammatory responses and perturbed epigenetic regulation, contribute to complex networks of communication among multiple organs. Particular emphasis is placed on the mechanisms through which the gut microbiota influences the ageing trajectories of distal organs such as skeletal muscle, the central nervous system, the heart, liver, lungs and kidneys, primarily through the modulation of microbial metabolites and immune responses. Furthermore, we propose emerging intervention strategies targeting the gut or its microbiota that hold promise for mitigating ageing-associated disorders. We also discuss the potential applications of personalized interventions and precision nutrition in delaying ageing and preventing related diseases. By integrating the most recent advances in the field, this review broadens current understanding of the mechanisms underlying gut–organ communication in ageing and provides new conceptual and translational perspectives for future clinical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.